Arrowhead Pharmaceuticals (ARWR) Enterprise Value (2010 - 2026)
Arrowhead Pharmaceuticals (ARWR) posted Enterprise Value of -$1.8 billion for Q1 2026, down 95.07% on a QoQ basis from -$922.3 million in Q4 2025, and down 64.08% year-over-year from -$5.0 billion in Q1 2025.
Arrowhead Pharmaceuticals (ARWR) Enterprise Value (2010 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals' Enterprise Value history runs 17 years deep, the most recent figure standing at -$1.8 billion for Q1 2026.
- Quarterly Enterprise Value fell 64.08% year-over-year to -$1.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.8 billion (down 64.08% YoY) and the FY2025 annual result came in at -$882.0 million, down 30.6% from the prior year.
- Enterprise Value was -$1.8 billion for Q1 2026 at Arrowhead Pharmaceuticals, down from -$922.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$88.2 million in Q3 2022 and bottomed at -$1.8 billion in Q1 2026.
- A 5-year average of -$613.8 million and a median of -$482.5 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2022 — Enterprise Value surged 71.66% — and 2023, when it sank 339.76%.
- Arrowhead Pharmaceuticals' Enterprise Value stood at -$482.5 million in 2022, then jumped by 57.1% to -$207.0 million in 2023, then plunged by 165.4% to -$549.4 million in 2024, then tumbled by 67.88% to -$922.3 million in 2025, then plunged by 95.07% to -$1.8 billion in 2026.
- Business Quant data shows ARWR's Enterprise Value at -$1.8 billion in Q1 2026, -$922.3 million in Q4 2025, and -$882.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - | -1.80 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.80 Bn |
| Dec 31, 2025 | -922.34 Mn |
| Sep 30, 2025 | -882.00 Mn |
| Jun 30, 2025 | -902.89 Mn |
| Mar 31, 2025 | -1.10 Bn |
| Dec 31, 2024 | -549.40 Mn |
| Sep 30, 2024 | -675.34 Mn |
| Jun 30, 2024 | -428.27 Mn |
| Mar 31, 2024 | -511.49 Mn |
| Dec 31, 2023 | -207.01 Mn |
| Sep 30, 2023 | -387.81 Mn |
| Jun 30, 2023 | -434.58 Mn |
| Mar 31, 2023 | -462.67 Mn |
| Dec 31, 2022 | -482.50 Mn |
| Sep 30, 2022 | -88.19 Mn |
| Jun 30, 2022 | -396.29 Mn |
| Mar 31, 2022 | -208.98 Mn |
| Dec 31, 2021 | -112.54 Mn |
| Sep 30, 2021 | -311.16 Mn |
| Jun 30, 2021 | -389.92 Mn |